Results 71 to 80 of about 57,888 (323)
Novel therapeutic targets for chronic visceral pain in gastrointestinal disorders
British Journal of Pharmacology, EarlyView.Chronic visceral pain imposes a major clinical challenge in gastroenterology and beyond, profoundly impacting patients' quality of life. However, limited understanding of its complex, multifaceted pathophysiology, encompassing both peripheral and central mechanisms, continues to impede the development of effective management strategies.
Fleur Veldman +3 more
wiley +1 more source
Essential updates 2018/2019: Colorectal (benign)
Annals of Gastroenterological Surgery, 2020 This review outlines current topics on the surgical treatment of benign colorectal diseases, with a focus on inflammatory bowel disease (IBD) and diverticulitis.
Takayuki Ogino +4 more
doaj +1 more source
Elective Surgery for Diverticulitis in Swiss Hospitals
Frontiers in Surgery, 2021 Objective: To assess current management of diverticulitis in Switzerland.Methods: Prospective observational study of diverticulitis management and outcomes in surgical departments over a 3-month time period.
Seraina Faes +176 more
doaj +1 more source
Headache: The Journal of Head and Face Pain, EarlyView.Abstract Objective To assess the safety, tolerability, and treatment effects of rimegepant 75 mg every other calendar day (EOD) for the preventive treatment of migraine in a 52‐week, open‐label extension (OLE) study. Background Rimegepant is an oral small molecule calcitonin gene–related peptide receptor antagonist approved for the acute treatment of ...
David Kudrow +3 more
wiley +1 more source
Therapeutic Advances in Gastroenterology, 2018 Background: Scarce data are available on the epidemiological trend of diverticulitis and its financial burden in Italy. The aim of this work was to explore a potential variation in the rate and costs of hospital admissions for uncomplicated and ...
Simona Cammarota +9 more
doaj +1 more source
Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open‐label extension study
Journal of the European Academy of Dermatology and Venereology, EarlyView.This study evaluated long‐term safety and efficacy in patients with moderate‐to‐severe atopic dermatitis. Patients with and without previous nemolizumab experience received nemolizumab 30 mg Q4W plus TCS/TCI. Nemolizumab was well‐tolerated through 104 weeks with clinically meaningful improvements in disease signs and symptoms.
Matthias Augustin +24 more
wiley +1 more source
Global Medical GeneticsBackground: Previous studies have suggested a potential link between the gut microbiota and diverticulitis. However, the causal relationships as well as underlying mechanisms remain unclear. Methods: The causal effects of gut microbiota on diverticulosis
Wende Hao, Zhenjun Wang, Huachong Ma
doaj +1 more source
Epiploic Appendagitis Mimicking Recurrent Diverticulitis
Case Reports in Surgery, 2018 Here, we report a case in which a patient with an extensive history of diverticulitis of the sigmoid colon presented with left lower quadrant abdominal pain similar to her previous episodes of diverticulitis.
R. Plummer +3 more
doaj +1 more source
Smoking Is Associated with an Increased Risk for Surgery in Diverticulitis: A Case Control Study. [PDF]
PLoS ONE, 2016 Cigarette smoking increases the risk of surgery in Crohn's disease. However, the effect of smoking on the need for surgery for diverticulitis is unknown.We evaluated whether smoking was a risk factor for surgery among patients admitted to hospital with ...
Michael J Diamant +9 more
doaj +1 more source
Neurogastroenterology &Motility, EarlyView.The 4‐item revised version of the Hays model from the PROMIS Global Health Scale exhibits stronger psychometric properties than the original model. This ultra‐brief assessment tool is a reliable measure for evaluating quality of life in both gastrointestinal and non‐gastrointestinal cohorts.
Pragalathan Apputhurai +5 more
wiley +1 more source